Woodstock Corp decreased its stake in shares of Johnson & Johnson (NYSE:JNJ) by 0.2% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 92,799 shares of the company’s stock after selling 174 shares during the quarter. Johnson & Johnson makes up about 1.9% of Woodstock Corp’s investment portfolio, making the stock its 11th largest position. Woodstock Corp’s holdings in Johnson & Johnson were worth $15,252,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Trust Asset Management LLC raised its stake in Johnson & Johnson by 80.5% during the third quarter. Trust Asset Management LLC now owns 13,363 shares of the company’s stock worth $1,989,000 after purchasing an additional 5,960 shares during the period. Polar Capital LLP grew its position in Johnson & Johnson by 657.6% in the third quarter. Polar Capital LLP now owns 1,207,177 shares of the company’s stock worth $179,725,000 after acquiring an additional 1,047,825 shares during the period. OLD Mission Capital LLC acquired a new stake in Johnson & Johnson during the third quarter worth $362,000. Global Trust Asset Management LLC grew its holdings in shares of Johnson & Johnson by 3.1% during the 3rd quarter. Global Trust Asset Management LLC now owns 5,504 shares of the company’s stock worth $811,000 after purchasing an additional 166 shares during the period. Finally, Te Ahumairangi Investment Management Ltd acquired a new stake in shares of Johnson & Johnson during the 3rd quarter worth about $5,694,000. 67.25% of the stock is currently owned by institutional investors.
NYSE JNJ traded up $0.25 during trading on Thursday, reaching $163.86. 42,300 shares of the company’s stock were exchanged, compared to its average volume of 8,177,090. The company has a 50 day moving average price of $161.06 and a two-hundred day moving average price of $154.38. The stock has a market cap of $431.40 billion, a P/E ratio of 25.76, a price-to-earnings-growth ratio of 3.06 and a beta of 0.70. Johnson & Johnson has a 1 year low of $133.65 and a 1 year high of $173.65. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.24 and a current ratio of 1.48.
JNJ has been the subject of several research analyst reports. Credit Suisse Group increased their target price on shares of Johnson & Johnson from $168.00 to $193.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 27th. Cantor Fitzgerald increased their price objective on shares of Johnson & Johnson from $180.00 to $200.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 26th. Wells Fargo & Company raised their price target on Johnson & Johnson from $175.00 to $190.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 27th. JPMorgan Chase & Co. boosted their price objective on Johnson & Johnson from $157.00 to $175.00 and gave the company a “neutral” rating in a report on Wednesday, January 27th. Finally, Raymond James increased their price target on shares of Johnson & Johnson from $158.00 to $183.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 27th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $178.60.
Johnson & Johnson Profile
Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR.
Featured Article: Stochastic Momentum Index (SMI)
Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.